The BLA situation is garbage. Fife situation too. No denying that. But everything else Leronlimab just gets more and more amazing.
Too much good stuff coming. The positive data is building. The positive anecdotes are overwhelming in number. Sooner or later LL won’t be denied, in spite of any NP flaws.
Brazil Covid. Cancer. NASH.
Potential is epic and the share price will reflect it sooner or later.
Or, people could vote for the 13D and slam on the brakes for another 1-2 years.
I’d rather go full steam ahead as-is. 13D donors should have spent the $$ on adding more shares.